Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer

NCT01870037 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Placebo (PBS-20% sucrose)
DRUG: hMaxi-K

Sponsor

Urovant Sciences GmbH

Collaborators

[object Object]